Top

Published in:

01-02-2011 | Invited Commentary

Henna as a Durable Preoperative Skin Marker

Author: B. Ramana

Published in: World Journal of Surgery | Issue 2/2011

Excerpt

One of the cloudy areas of surgical practice has been wrong-site surgery along with wrong-patient and inappropriate surgery. It has been estimated that these “never-again events” occur to the tune of 75 cases each year in the United States [1]. Not surprisingly, figures for the Third and Fourth Worlds are not forthcoming as the twenty-first century has seen little that is notable about data tracking in most countries. …

Seiden SC, Barach P (2006) Wrong-side/wrong-site, wrong-procedure, and wrong-patient adverse events: are they preventable? Arch Surg 141:931–939CrossRefPubMed

Mehendale VG, Chaudhari NC, Shenoy SN, et al (2010) Henna as a durable preoperative skin marker. World J Surg. doi:10.1007/s00268-010-0864-y

Stahel PF, Mehler PS, Clarke TJ et al (2009) The 5th anniversary of the “Universal Protocol”: pitfalls and pearls revisited. Patient Saf Surg 3:14. doi:10.1186/1754-9493-3-14 CrossRefPubMed

Gormley GJ, Dempster M, Best R (2008) Right-left discrimination among medical students: questionnaire and psychometric study. BMJ 337:a2826. doi:10.1136/bmj.a2826 CrossRefPubMed

Title: Henna as a Durable Preoperative Skin Marker
Author: B. Ramana
Publication date: 01-02-2011
Publisher: Springer-Verlag
Published in: World Journal of Surgery / Issue 2/2011
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-010-0879-4

At a glance: The STEP trials

Springer Medicine

Henna as a Durable Preoperative Skin Marker

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2011

Analysis of the Clinicopathologic Features of Papillary Thyroid Microcarcinoma Based on 7-mm Tumor Size

Impact of Low-dose Vasopressin on Trauma Outcome: Prospective Randomized Study

Assessment of Quality of Life After Gastrectomy Using EORTC QLQ-C30 and STO22

Clinical Outcome of Hepatectomy for Hepatocellular Carcinomas ≤2 cm

Living-donor Liver Transplantation for Progressive Familial Intrahepatic Cholestasis

Risk Factors for the Development of Metachronous Liver Metastasis in Colorectal Cancer Patients After Curative Resection